146 related articles for article (PubMed ID: 31485674)
1. In vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation model.
Nishizawa T; Nakano K; Fujii E; Komura D; Kuroiwa Y; Ishimaru C; Monnai M; Aburatani H; Ishikawa S; Suzuki M
Oncol Rep; 2019 Nov; 42(5):1745-1754. PubMed ID: 31485674
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-Function
Zhang H; Schaefer A; Wang Y; Hodge RG; Blake DR; Diehl JN; Papageorge AG; Stachler MD; Liao J; Zhou J; Wu Z; Akarca FG; de Klerk LK; Derks S; Pierobon M; Hoadley KA; Wang TC; Church G; Wong KK; Petricoin EF; Cox AD; Lowy DR; Der CJ; Bass AJ
Cancer Discov; 2020 Feb; 10(2):288-305. PubMed ID: 31771969
[TBL] [Abstract][Full Text] [Related]
3. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
[TBL] [Abstract][Full Text] [Related]
4. RhoA G17E/Vav1 Signaling Induces Cancer Invasion via Matrix Metalloproteinase-9 in Gastric Cancer.
Nakamura S; Kitazawa M; Miyagawa Y; Koyama M; Miyazaki S; Hondo N; Muranaka F; Tokumaru S; Yamamoto Y; Ehara T; Matsumura T; Takeoka M; Soejima Y
Technol Cancer Res Treat; 2023; 22():15330338221146024. PubMed ID: 36617975
[TBL] [Abstract][Full Text] [Related]
5. RHOA
Schaefer A; Hodge RG; Zhang H; Hobbs GA; Dilly J; Huynh MV; Goodwin CM; Zhang F; Diehl JN; Pierobon M; Baldelli E; Javaid S; Guthrie K; Rashid NU; Petricoin EF; Cox AD; Hahn WC; Aguirre AJ; Bass AJ; Der CJ
Sci Signal; 2023 Dec; 16(816):eadg5289. PubMed ID: 38113333
[TBL] [Abstract][Full Text] [Related]
6. c-Met-dependent phosphorylation of RhoA plays a key role in gastric cancer tumorigenesis.
Liu J; Li S; Chen S; Chen S; Geng Q; Xu D
J Pathol; 2019 Sep; 249(1):126-136. PubMed ID: 31056743
[TBL] [Abstract][Full Text] [Related]
7. RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases.
Ushiku T; Ishikawa S; Kakiuchi M; Tanaka A; Katoh H; Aburatani H; Lauwers GY; Fukayama M
Gastric Cancer; 2016 Apr; 19(2):403-411. PubMed ID: 25823974
[TBL] [Abstract][Full Text] [Related]
8. Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer.
Chang HR; Nam S; Lee J; Kim JH; Jung HR; Park HS; Park S; Ahn YZ; Huh I; Balch C; Ku JL; Powis G; Park T; Jeong JH; Kim YH
Oncotarget; 2016 Dec; 7(49):81435-81451. PubMed ID: 27806312
[TBL] [Abstract][Full Text] [Related]
9. Aberrant alternative splicing of RHOA is associated with loss of its expression and activity in diffuse-type gastric carcinoma cells.
Miyamoto S; Nagamura Y; Nakabo A; Okabe A; Yanagihara K; Fukami K; Sakai R; Yamaguchi H
Biochem Biophys Res Commun; 2018 Jan; 495(2):1942-1947. PubMed ID: 29247652
[TBL] [Abstract][Full Text] [Related]
10. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
[TBL] [Abstract][Full Text] [Related]
11. Identification of "regulation of RhoA activity panel" as a prognostic and predictive biomarker for gastric cancer.
Huang W; Zhao S; Zhang C; Li Z; Ge S; Lian B; Feng H; Wang K; Xu R; Ji J; Gao J; Shi W; Shen L
Aging (Albany NY); 2020 Dec; 13(1):714-734. PubMed ID: 33288739
[TBL] [Abstract][Full Text] [Related]
12. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells.
Xu XT; Song QB; Yao Y; Ruan P; Tao ZZ
Hepatogastroenterology; 2012; 59(120):2523-6. PubMed ID: 22584506
[TBL] [Abstract][Full Text] [Related]
14. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma.
Kakiuchi M; Nishizawa T; Ueda H; Gotoh K; Tanaka A; Hayashi A; Yamamoto S; Tatsuno K; Katoh H; Watanabe Y; Ichimura T; Ushiku T; Funahashi S; Tateishi K; Wada I; Shimizu N; Nomura S; Koike K; Seto Y; Fukayama M; Aburatani H; Ishikawa S
Nat Genet; 2014 Jun; 46(6):583-7. PubMed ID: 24816255
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.
Korourian A; Roudi R; Shariftabrizi A; Madjd Z
Exp Biol Med (Maywood); 2017 Dec; 242(18):1842-1847. PubMed ID: 28836853
[TBL] [Abstract][Full Text] [Related]
16. MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA.
Chen Z; Liu S; Xia Y; Wu K
Med Sci Monit; 2016 Dec; 22():4679-4691. PubMed ID: 27904131
[TBL] [Abstract][Full Text] [Related]
17. Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.
Yoon JH; Choi WS; Kim O; Choi BJ; Nam SW; Lee JY; Park WS
Gastric Cancer; 2017 Mar; 20(2):274-285. PubMed ID: 27250838
[TBL] [Abstract][Full Text] [Related]
18. DGC-specific
Nishizawa T; Nakano K; Harada A; Kakiuchi M; Funahashi SI; Suzuki M; Ishikawa S; Aburatani H
Oncotarget; 2018 May; 9(33):23198-23207. PubMed ID: 29796182
[No Abstract] [Full Text] [Related]
19. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
Ge F; Wang C; Wang W; Liu W; Wu B
Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
[TBL] [Abstract][Full Text] [Related]
20. [Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo].
Jiang WY; Kang JL; Wang XX; Yang WJ; Nie ML; Zhou C
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):778-83. PubMed ID: 24406137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
